GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adventa Bhd (XKLS:7191) » Definitions » Debt-to-EBITDA

Adventa Bhd (XKLS:7191) Debt-to-EBITDA : 0.24 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Adventa Bhd Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Adventa Bhd's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was RM0.79 Mil. Adventa Bhd's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was RM0.00 Mil. Adventa Bhd's annualized EBITDA for the quarter that ended in Mar. 2024 was RM3.28 Mil. Adventa Bhd's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 0.24.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Adventa Bhd's Debt-to-EBITDA or its related term are showing as below:

XKLS:7191' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.87   Med: 0.24   Max: 6.07
Current: -0.1

During the past 13 years, the highest Debt-to-EBITDA Ratio of Adventa Bhd was 6.07. The lowest was -0.87. And the median was 0.24.

XKLS:7191's Debt-to-EBITDA is ranked worse than
100% of 436 companies
in the Medical Devices & Instruments industry
Industry Median: 1.26 vs XKLS:7191: -0.10

Adventa Bhd Debt-to-EBITDA Historical Data

The historical data trend for Adventa Bhd's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adventa Bhd Debt-to-EBITDA Chart

Adventa Bhd Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.74 0.35 0.10 -0.17 -0.87

Adventa Bhd Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.35 -1.20 -2.98 -0.37 0.24

Competitive Comparison of Adventa Bhd's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Adventa Bhd's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adventa Bhd's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Adventa Bhd's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Adventa Bhd's Debt-to-EBITDA falls into.



Adventa Bhd Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Adventa Bhd's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.068 + 5.67) / -8.945
=-0.87

Adventa Bhd's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.789 + 0) / 3.284
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Adventa Bhd  (XKLS:7191) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Adventa Bhd Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Adventa Bhd's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Adventa Bhd (XKLS:7191) Business Description

Traded in Other Exchanges
N/A
Address
No. 21, Jalan Tandang 51/205A, Seksyen 51, Petaling Jaya, SGR, MYS, 46050
Adventa Bhd is engaged in the business of medical services and related supplies manufacturing. The company's segments include Healthcare Business, Warehousing provider, and Corporate. It generates maximum revenue from the Healthcare Business segment. The healthcare business segment comprises the supply of healthcare and related products and services to hospitals, healthcare centres, and pharmacies. Previously, it also included the renal dialysis business which are both for home and centre-based treatments, serving both the domestic and export markets. Geographically, it derives a majority of revenue from Malaysia.

Adventa Bhd (XKLS:7191) Headlines

No Headlines